Milestones in progression of primary pneumonic plague in cynomolgus macaques

Keyphrases

• Pneumonic Plague 100%
• Bacteremia 100%
• Disease Progression 100%
• Cynomolgus Macaque 100%
• Lung Tissue 66%
• Aerosol Route 66%
• Inflammation 33%
• Plague 33%
• Vaccine Antigen 33%
• Yersinia Pestis 33%
• Human Disease 33%
• CCL3 33%
• Murine Model 33%
• Inhalational 33%
• Chemokines 33%
• Chemokine (C-C motif) Ligand 2 (CCL2) 33%
• Clinical Features 33%
• Fever 33%
• Quantitative PCR 33%
• Interleukin-1β 33%
• Heart Rate 33%
• Nonhuman Primate Model 33%
• Bioweapons 33%
• Systemic Response 33%
• Culture Method 33%
• Moribund 33%
• 16S Ribosomal RNA (16S rRNA) 33%
• Inflammatory Phase 33%
• Yersinia 33%
• Bacterial Burden 33%
• Lobar Pneumonia 33%
• Dose Equivalent 33%
• Necropsy 33%
• Macaca Fascicularis 33%
• Tachypnea 33%
• Respiratory Rate 33%
• Effective Dose 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pneumonic Plague 100%
• Macaca fascicularis 100%
• Disease Exacerbation 75%
• Bacteremia 75%
• Disease 25%
• Yersinia Pestis 25%
• Clinical Feature 25%
• Inflammation 25%
• Cytokine 25%
• Chemokine 25%
• Anti-Inflammatory Drug 25%
• RNA 16S 25%
• Dying 25%
• Interleukin 1 25%
• Tachypnea 25%
• Yersinia 25%

Immunology and Microbiology

• Macaca fascicularis 100%
• Vaccine Efficacy 50%
• Cytokine 25%
• Yersinia Pestis 25%
• CCL3 25%
• Chemokine 25%
• Quantitative Reverse Transcription Polymerase Chain Reaction 25%
• CCL2 25%
• Interleukin 1 25%
• Bacterial Load 25%
• Yersinia 25%
• Dying 25%